Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled trial
L. Riley Gournay, Morgan L. Ferretti, Sarah A. Bilsky, et al.
Psychopharmacology (2023) Vol. 240, Iss. 10, pp. 2147-2161
Closed Access | Times Cited: 10

Showing 10 citing articles:

Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders
Olivier J. Manzoni, Antonia Manduca, Viviana Trezza
Trends in Pharmacological Sciences (2025)
Open Access | Times Cited: 1
Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150mg/ml) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial
Prasad Rao Gundugurti, Nagaraju Banda, Siva Sankara Rao Yadlapalli, et al.
Asian Journal of Psychiatry (2024) Vol. 97, pp. 104073-104073
Open Access | Times Cited: 6
Antimicrobial, Probiotic, and Immunomodulatory Potential of Cannabis sativa Extract and Delivery Systems
Anna Stasiłowicz-Krzemień, Daria Szymanowska, Piotr Szulc, et al.
Antibiotics (2024) Vol. 13, Iss. 4, pp. 369-369
Open Access | Times Cited: 4
ANXIOLYTICS: Origins, drug discovery, and mechanisms
Jeffrey M. Witkin, James E. Barrett
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173858-173858
Closed Access | Times Cited: 4
Medical Cannabis: From Research Breakthroughs to Shifting Public Perceptions and Ensuring Safe Use
Muhammad Kamal Hossain, Han‐Jung Chae
Integrative Medicine Research (2024) Vol. 13, Iss. 4, pp. 101094-101094
Open Access | Times Cited: 4
The Impact of Cannabidiol Treatment on Anxiety Disorders: A Systematic Review of Randomized Controlled Clinical Trials
Carly de Faria Coelho, Rodolfo P. Vieira, Osvaldo Soares Araújo-Junior, et al.
Life (2024) Vol. 14, Iss. 11, pp. 1373-1373
Open Access | Times Cited: 2
The effects of acute versus repeated cannabidiol administration on trauma‐relevant emotional reactivity: A double‐blind, randomized, placebo‐controlled trial
L. Riley Gournay, Morgan L. Ferretti, Annamarie Stehli Nguyen, et al.
Journal of Traumatic Stress (2024) Vol. 37, Iss. 6, pp. 946-958
Closed Access
The impact of cannabidiol placebo on amygdala-based neural responses to an acute stressor
Robin N Perry, Mikeala A Ethier-Gagnon, Carl Helmick, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 11, pp. 935-948
Open Access
Cannabidiol Supplements in Romania: Bridging the Gap Between Marketed Claims and Clinical Reality
Corina Andrei, George Mihai Nițulescu, Georgiana Nițulescu, et al.
Pharmacy (2024) Vol. 12, Iss. 6, pp. 176-176
Open Access
Page 1

Scroll to top